Samir Kaul - May 5, 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John J. Demeter, as attorney-in-fact for Samir Kaul
Stock symbol
GH
Transactions as of
May 5, 2021
Transactions value $
-$714,242
Form type
4
Date filed
5/7/2021, 04:41 PM
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Sale -$181K -1.3K -6.49% $140.04 18.6K May 5, 2021 By Trust F1, F2, F3
transaction GH COMMON STOCK Sale -$42.5K -300 -1.61% $141.64 18.3K May 5, 2021 By Trust F1, F3, F4
transaction GH COMMON STOCK Sale -$71.3K -500 -2.73% $142.62 17.8K May 5, 2021 By Trust F1, F3, F5
transaction GH COMMON STOCK Sale -$202K -1.41K -7.87% $143.49 16.4K May 5, 2021 By Trust F1, F3, F6
transaction GH COMMON STOCK Sale -$130K -900 -5.47% $144.50 15.5K May 5, 2021 By Trust F1, F3, F7
transaction GH COMMON STOCK Sale -$43.6K -300 -1.93% $145.18 15.2K May 5, 2021 By Trust F1, F3, F8
transaction GH COMMON STOCK Sale -$43.9K -300 -1.97% $146.27 14.9K May 5, 2021 By Trust F1, F3, F9
holding GH COMMON STOCK 4.06K May 5, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.63 to $140.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within each of the ranges set forth in this Form.
F3 Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.99 to $141.98 inclusive.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.04 to $143.03 inclusive.
F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.07 to $144.01 inclusive.
F7 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.10 to $144.85 inclusive.
F8 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.10 to $145.29 inclusive.
F9 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.10 to $146.40 inclusive.